CBAM Introduction And SELT Acquisition Will Improve Future Competitiveness

AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Published
10 Feb 25
Updated
08 Aug 25
AnalystConsensusTarget's Fair Value
zł885.80
3.2% overvalued intrinsic discount
08 Aug
zł914.50
Loading
1Y
19.5%
7D
5.5%

Author's Valuation

zł885.8

3.2% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Increased 1.80%

Shared on23 Apr 25
Fair value Increased 0.11%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Decreased 0.026%

AnalystConsensusTarget has increased revenue growth from 8.0% to 9.1%.

Shared on09 Apr 25
Fair value Increased 12%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 2.54%

AnalystConsensusTarget has decreased revenue growth from 8.5% to 7.3% and increased shares outstanding growth rate from 0.0% to 0.0%.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 15%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on13 Mar 25
Fair value Increased 1.86%